Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC25A21-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANO10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC23B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDPCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAPER - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF302 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMMD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WWP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AASDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AXIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGAV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928238 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H3E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on